- Home
- GLPG vs PPBI Comparison
GLPG vs PPBI Comparison
Compare GLPG & PPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- PPBI
- Stock Information
- Founded
- GLPG 1999
- PPBI 1983
- Country
- GLPG Belgium
- PPBI United States
- Employees
- GLPG N/A
- PPBI N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- PPBI Major Banks
- Sector
- GLPG Health Care
- PPBI Finance
- Exchange
- GLPG Nasdaq
- PPBI Nasdaq
- Market Cap
- GLPG 2.0B
- PPBI 2.2B
- IPO Year
- GLPG 2005
- PPBI 1997
- Fundamental
- Price
- GLPG $33.01
- PPBI $21.75
- Analyst Decision
- GLPG Sell
- PPBI Buy
- Analyst Count
- GLPG 4
- PPBI 4
- Target Price
- GLPG $25.33
- PPBI $27.25
- AVG Volume (30 Days)
- GLPG 372.1K
- PPBI 1.2M
- Earning Date
- GLPG 07-23-2025
- PPBI 07-24-2025
- Dividend Yield
- GLPG N/A
- PPBI 6.09%
- EPS Growth
- GLPG N/A
- PPBI N/A
- EPS
- GLPG N/A
- PPBI 1.43
- Revenue
- GLPG $323,674,692.00
- PPBI $584,278,000.00
- Revenue This Year
- GLPG $0.78
- PPBI N/A
- Revenue Next Year
- GLPG N/A
- PPBI $6.74
- P/E Ratio
- GLPG N/A
- PPBI $15.21
- Revenue Growth
- GLPG 5.43
- PPBI 48.04
- 52 Week Low
- GLPG $22.36
- PPBI $18.06
- 52 Week High
- GLPG $33.86
- PPBI $30.28
- Technical
- Relative Strength Index (RSI)
- GLPG 67.37
- PPBI 48.24
- Support Level
- GLPG $31.98
- PPBI $21.15
- Resistance Level
- GLPG $33.66
- PPBI $22.77
- Average True Range (ATR)
- GLPG 0.85
- PPBI 0.64
- MACD
- GLPG 0.17
- PPBI -0.06
- Stochastic Oscillator
- GLPG 88.39
- PPBI 37.04
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.
About PPBI Pacific Premier Bancorp Inc
Pacific Premier Bancorp Inc through its subsidiaries, provides banking products and services. It offers cash management, electronic banking services, credit facilities, and retirement accounts, among others.